DURBAN – Pharmaceutical firm Adcock Ingram lifted profit 20 percent despite consumers being under pressure.
South Africans suffering from allergies and flu piled into drugmaker Adcock Ingram’s over-the-counter (OTC) medicine, leading to some brands, such as Adco-Dol, Allergex, Alcophyllex and Napamol showing double-digit growth in the year to end June.
OTC drugs had seen a turnover improvement of 7.6 percent to R2bn.
Adcock said yesterday that the group reported 20 percent increase in trading profit to R866m while turnover increased by 10.2 percent to R6.54 billion. Headline earnings per share (Heps) from continuing operations increased by 26 percent to 387.7 cents a share.
Chief executive Andy Hall said the positive results were achieved through continued investment in their well-established brands, improved factory efficiencies and a relentless focus on customer service and product quality.